Clinical Trial: Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)

Brief Summary: Guanfacine may preferentially reduce craving and improve cognitive control in women with Alcohol Use Disorder (AUD), compared to men. As these behaviors are related to relapse, the objectives of this study are to conduct a 10-week out-patient clinical trial to examine the effects of Guanfacine Extended Release (XR; 3mgs) versus placebo on drinking measures in women with AUD.